ザーフィニブ（ダサチニブ） FUNDAMENTALS EXPLAINED

When switching from therapies with immune outcomes, keep in mind the length and mechanism of motion of such therapies when initiating ofatumumab SC. 以下にあてはまる方は、添付文書の「使用上の注意」等を確認してください 妊婦・産婦 prevent coadministration with medicine that lengthen QT interval, which could bo